The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.

The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.

Item
http://www.wikidata.org/entity/Q38870068
miR-143 is associated with proliferation and apoptosis involving ERK5 in HeLa cellsModulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain n-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs.Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.ATM/MAPK7 crosstalk in cancer.Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity.Mitogen-activated protein kinase signaling pathway in oral cancer.Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition.ERK5 is activated by oncogenic BRAF and promotes melanoma growth.A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC.Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
P2860

The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.

Item
http://www.wikidata.org/entity/Q38870068
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
@en
type
label
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
@en
prefLabel
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
@en
P2093
P304
P31
P356
10.1016/J.DRUDIS.2016.06.010
P433
P478
P50
P577
P698